D-1174-2017 Class II Terminated

Recalled by Medisca, Inc. — Plattsburgh, NY

FDA drug recall D-1174-2017 was initiated by Medisca, Inc. on Sep 14, 2017 and is designated Class II. Reason for recall: CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use. The recall status is terminated (terminated Dec 4, 2018). Affected quantity: 34,600 g.

Recall details

Product Type
Drugs
Report Date
Sep 27, 2017
Initiation Date
Sep 14, 2017
Termination Date
Dec 4, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
34,600 g

Product description

Aminocaproic Acid, USP (6-Aminohexanoic Acid) active pharmaceutical ingredient, packaged in a) 100 g jar (NDC 38779-0989-05, b) 1 kg jar (NDC 38779-0989-09), and 25 kg drum (NDC 38779-0989-07), Rx only, Packed by Medisca Inc., Plattsburgh, NY 12901, CAS: 60-32-1. 38779-0989-05; jar, 300 ml, white HDPE 38779-0989-07; drum, 15 gallon, Fiber 38779-0989-09; 2.8L, white, HDPE

Reason for recall

CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use.

Distribution pattern

Nationwide in the USA

Code information

Lots# 143595/A,143595/B,143595/D, Exp 02/28/20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1174-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1174-2017. Report a data issue: hello@regdatalab.com.